Xeris Biopharma Holdings (XERS) Gross Profit (2020 - 2026)
Xeris Biopharma Holdings' Gross Profit came in at $79.59 million for Q2 2026, up 33.4% from $59.64 million a year earlier and up 9.7% from the prior quarter.
Powered by 
Analysis
Xeris Biopharma Holdings (XERS) Gross Profit (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Xeris Biopharma Holdings reported Gross Profit of $290.39 million, up 43.5% year-over-year; for FY2025, it was $249.28 million, up 50.0% from FY2024.
- Gross Profit has increased in each of the last five years, with a five-year compound annual growth rate of 86.3% (FY2020 to FY2025).
- Going back by year, Gross Profit was $166.24 million in FY2024 (+22.9%), $135.27 million in FY2023 (+54.4%), $87.61 million in FY2022 (+141.5%) and $36.27 million in FY2021 (+226.6%).
- The Q2 2026 figure represents the highest quarterly Gross Profit in data going back to Q3 2020.
- Year-over-year, Gross Profit has increased for 20 consecutive quarters, with growth averaging 39.2% over the last eight quarters.
- The year-over-year growth in Gross Profit has ranged between 1.4% (Q3 2024) and 321.1% (Q4 2021) over the last five years.
- Business Quant data shows XERS's Gross Profit at $72.55 million (Q1 2026), $74.86 million (Q4 2025) and $63.38 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Xeris Biopharma Holdings | 2.89 Bn | 2.41 Bn | 94.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 94.80 Mn |
| Jun 30, 2026 | 79.59 Mn |
| Mar 31, 2026 | 72.55 Mn |
| Dec 31, 2025 | 74.86 Mn |
| Sep 30, 2025 | 63.38 Mn |
| Jun 30, 2025 | 59.64 Mn |
| Mar 31, 2025 | 51.39 Mn |
| Dec 31, 2024 | 50.62 Mn |
| Sep 30, 2024 | 40.68 Mn |
| Jun 30, 2024 | 40.28 Mn |
| Mar 31, 2024 | 34.67 Mn |
| Dec 31, 2023 | 36.82 Mn |
| Sep 30, 2023 | 40.12 Mn |
| Jun 30, 2023 | 30.45 Mn |
| Mar 31, 2023 | 27.88 Mn |
| Dec 31, 2022 | 26.85 Mn |
| Sep 30, 2022 | 24.47 Mn |
| Jun 30, 2022 | 20.50 Mn |
| Mar 31, 2022 | 22.07 Mn |
| Dec 31, 2021 | 29.86 Mn |
API Access
Xeris Biopharma Holdings Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=XERS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "XERS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=XERS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();